Activity of the morpholino anthracycline 3′-deamino-3′-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming unitsin vitro
- 1 June 1995
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 13 (2) , 125-131
- https://doi.org/10.1007/bf00872860
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Multidrug resistance in human cancerCritical Reviews in Oncology/Hematology, 1992
- Comparative cardiotoxicity of doxorubicin and a morpholino anthracycline derivative (KRN8602)Biochemical Pharmacology, 1991
- Establishment of a human leukemia subline resistant to the growth‐inhibitory effect of 12‐o‐tetradecanoylphorbol 13‐acetate (TPA) and showing non‐P‐glycoprotein‐mediated multi‐drug resistanceInternational Journal of Cancer, 1991
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990
- selection of Cancer Chemotherapy for a Patient by an In Vitro Assay Versus a ClinicianJNCI Journal of the National Cancer Institute, 1990
- 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceEuropean Journal of Cancer and Clinical Oncology, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Biphasic Effect of Vanadium Salts on In Vitro Tumor Colony GrowthThe International Journal of Cell Cloning, 1987
- Primary Bioassay of Human Tumor Stem CellsScience, 1977